0001437749-21-009538.txt : 20210422 0001437749-21-009538.hdr.sgml : 20210422 20210422083143 ACCESSION NUMBER: 0001437749-21-009538 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170712 FILED AS OF DATE: 20210422 DATE AS OF CHANGE: 20210422 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Payne Brian CENTRAL INDEX KEY: 0001736944 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-55557 FILM NUMBER: 21843343 MAIL ADDRESS: STREET 1: 1027 HUNTINGTON BLVD CITY: BELLE RIVER STATE: A6 ZIP: N0R 1A0 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEN BIOTECH INC CENTRAL INDEX KEY: 0001653821 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 BUSINESS PHONE: 226-344-0660 MAIL ADDRESS: STREET 1: 300-3295 QUALITY WAY CITY: WINDSOR STATE: A6 ZIP: N8T 3R9 3 1 rdgdoc.xml FORM 3 X0206 3 2017-07-12 0 0001653821 CEN BIOTECH INC CENBF 0001736944 Payne Brian 300-3295 QUALITY WAY WINDSOR, ONTARIO, CANADA A6 N8T 3R9 ONTARIO, CANADA 1 1 Vice President Common Stock 4285 D Brian Payne was appointed to his positions with CEN Biotech, Inc. (the "Issuer") on July 12, 2017 and owned 4,285 shares of common stock of the Issuer at such date. /s/ Brian Payne 2021-04-22